Bhami's Research Laboratory (BRL) is an innovative company established in 2014 by a team of experienced scientists and entrepreneurs in the biopharma industry. Specializing in the development of technologies for purification, high concentration injectable protein therapeutics formulations, and oral delivery of biotherapeutics, BRL's current focus is on therapeutic peptides.
The company has made significant strides over the past 8 years, developing 3 innovative technologies and filing 2 patents. BRL operates in the Biotechnology and Health Care industries, positioning itself at the forefront of cutting-edge advancements in life sciences. With its expertise in high concentration formulations, BRL has the potential to revolutionize drug delivery and enhance the efficiency of therapeutic treatments.
As a venture capitalist, considering BRL as a potential investment opportunity could be promising, with its track record of innovation and patents, particularly in the lucrative and vital field of biopharmaceuticals.
There is no investment information
No recent news or press coverage available for Bhami's Research Laboratory.